Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways
- PMID: 15117910
- DOI: 10.1161/01.HYP.0000127914.94292.76
Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways
Abstract
Hyperhomocysteinemia is an independent risk factor for the development of atherosclerosis. However, the underlying mechanism of endothelial cell injury in hyperhomocysteinemia has not been elucidated. In this study, we examined the effect of homocysteine (Hcy) on Fas-mediated apoptosis in endothelial cells. Hcy-induced upregulation of Fas in endothelial cells (ECs) in a dose-dependent manner. At the same time, Hcy increased intracellular peroxide in ECs. Hcy-induced Fas expression was inhibited by the treatment with catalase. Hcy increased NF-kappaB DNA binding activity, and adenovirus-mediated transfection of a Ikappa-B mutant (Ikappa-B mt) gene inhibited Hcy-induced Fas expression. ECs were sensitive to Fas-mediated apoptosis when exposed to Hcy. Under these condition, Ikappa-B mt protected ECs from Fas-mediated apoptosis. In addition, Hcy inhibited expression of the caspase-8 inhibitor FLICE-inhibitory protein (FLIP). Adenovirus-mediated transfection of constitutively active Akt gene abolished the Hcy-mediated downregulation of FLIP. These data suggest that upregulation of Fas expression and downregulation of FLIP is a mechanism through which Hcy induces EC apoptosis.
Comment in
-
Death receptor induced apoptosis: a new mechanism of homocysteine-mediated endothelial cell cytotoxicity.Hypertension. 2004 Jun;43(6):1168-70. doi: 10.1161/01.HYP.0000127811.48554.12. Epub 2004 Apr 19. Hypertension. 2004. PMID: 15096473 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
